Joanne Wan, Ph.D., DABT Senior Manager, Toxicology
Dr. Joanne Wan joined Intertek Scientific and Regulatory Consultancy in 2007. During this time, Dr. Wan has assisted clients with designing and implementing their nonclinical toxicology development strategies for products such as medical devices, dermal drugs, oncology drugs, and botanicals. This includes designing and outsourcing nonclinical toxicology and safety pharmacology programs, reviewing study protocols, on- and off-site study monitoring, reviewing study reports, and preparing regulatory submission documents. Dr. Wan has extensive experience working closely with the Regulatory Affairs team at Intertek to complete and co-ordinate regulatory submissions for her clients and to facilitate interactions with Regulatory Agencies. Dr. Wan has also provided medical writing services such as preparing literature-based safety and efficacy dossiers, writing Investigator’s Brochures, and preparing Pregnancy and Lactation label sections for drug products.
In addition to her work with the Pharmaceuticals & Healthcare group, Dr. Wan is also part of the team at Intertek that performs toxicology risk assessments (TRAs) of consumer products, cosmetics, art materials, and toys that are marketed in Canada and the United States. Dr. Wan also serves as a resource on general toxicology, dermal toxicology, and reproductive and developmental toxicity issues.
Dr. Wan is an active member of the Society of Toxicology of Canada and is currently serving as a member of the Program Committee for the Society’s Annual meeting (to 2020). She is also a Full member of the SOT and is a Board-Certified toxicologist.
